期刊文献+

拉米夫定联合干扰素-α治疗儿童慢性乙型肝炎27例 被引量:2

原文传递
导出
摘要 核苷类似物和IFN是两类抗HBV药物,因其作用机制不同,两者联合应用可能提高慢性乙型肝炎的疗效。有报道,联合治疗可提高HBeAg血清转换率,减少核苷类似物耐药的发生,但联合治疗儿童慢性乙型肝炎的疗效和安全性鲜有报道。本研究采用拉米夫定和IFN-α联合治疗儿童慢性乙型肝炎,现报道如下。
出处 《中华传染病杂志》 CAS CSCD 北大核心 2010年第11期687-688,共2页 Chinese Journal of Infectious Diseases
  • 相关文献

参考文献3

二级参考文献10

  • 1LokAS,MeMahon BJ.Chronic hepatitis B[].Hepatology.2007
  • 2Tenney DJ,Levine SM,Rose RE,et al.Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant tolamivedine[].Antimicrobial Agents and Chemotherapy.2004
  • 3Chang TT,Zhang Hui,Jia Jidong.Chronic hepatitis B:treatment alert[].Liver International.2006
  • 4Lai CL,Leung N,Teo EK,et al.A1-year trial of telbivudine,lamive-dine,and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B[].Gastroenterology.2005
  • 5van Bommel F,Wunsche T,Mauss S,et al.Comparison of adefovir and tenofovir inthe treatment of lamivedine-resistant hepatitis Bvirusinfection[].Hepatology.2004
  • 6Hadziyannis S,Tassopoulos N,Chang TT,et al.Long-termadefovir dipiv-oxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B:results after5years of therapy[].Hepatology.2005
  • 7Chang TT,Lai CL,Chien RN,et al.Four years of lamivudine treatment in Chinese patients with chronic hepatitis B[].Journal of Gastroenterology.2004
  • 8Lau DT,Everhart J,Kleiner DE,et al.Long-termfollow-up of patients with chronic hepatitis Btreated withinterferon alfa[].Gastroenterology.1997
  • 9Keeffe EB,Oieterich DT,Han S HB,et al.Atreatment alogorithmfor the management of chronic hepatitis B virus infection n the United States:an update[].Clinic Gastroenterol Hepatology.2006
  • 10LiawYF,Sung JJ,Chow WC,et al.Lamivedine for patients with chronic hepatitis B and advancedliver disease[].The New England Journal of Medicine.2004

共引文献14017

同被引文献12

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部